BackBrooklyn ImmunoTherapeutics Overview

Brooklyn ImmunoTherapeutics Operating Income

Operating Income for BTX.

Quarterly Operating Income

$-2259000.00
↓ 58.96% YoY

As of Sep 30, 2024

Annual Operating Income (TTM)

$-18742000.00
↓ 6.79% YoY

Trailing 12 months ending Sep 30, 2024

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin